Having The Snooze Blues? State Of The Science On Sleep In Mood Disorders
Sleep disturbance is a predominant symptom associated with depression, impacting ~75% of those diagnosed with depression. Insomnia, hypersomnia, and obstructive sleep apnea are all highly prevalent among those with depression.1 An estimated 40% of individuals among the general and healthcare populations have reported sleep problems because of the COVID pandemic, with certain gender and ethnic groups being impacted at a disproportionate rate.2 Given the positive correlation between sleep disturbances and depression, this has raised concerns among experts for the potential development of mood disorders more broadly across our society.
In this webinar, Dr. Beth DiNapoli moderates an enlightening discussion on the current state of the science in sleep and depression with experts in psychiatry and sleep, Drs. Vladimir Maletic and Marie Anne Gebara. They will reflect on scientific advances in understanding the complex, bidirectional relationship between sleep disturbances and depression, as well as the potential long-term impact of the SARS-CoV-2 pandemic on sleep quality and mood disorders. Educational and supportive resources for improving sleep hygiene will be provided. Join us for this unique opportunity to learn and grow as we all strive to improve our quality of life in this para-pandemic world!
-
Intro & Objectives
00:00:00 -
Provide a brief overview of sleep statistics & clinical assessment
00:01:48 -
Discuss the relationship between sleep & depressive disorders
00:25:08 -
Highlight strategies to manage insomnia, improve sleep quality, & digitally monitor sleep patterns
00:34:05 -
Summary & Closing
01:01:43
Vladimir Maletic, MD
Serves as Clinical Professor, Psychiatry/Behavioral Science, University of South Carolina School of Medicine Greenville, SC
Marie Anne Gebara, MD
Assistant Professor of Psychiatry, University of Pittsburgh
Elizabeth DiNapoli, PhD (OPDC)
Senior Medical Science Liaison
References:
- Newsom R. www.sleepfoundation.org/mental-health/depression-and-sleep. Accessed on November 2021.
- Mandelkorn U, et al. Escalation of sleep disturbances amid the COVID-19 pandemic: a cross-sectional international study. J Clin Sleep Med. 2021;17(1):45–53.
Vladimir Maletic, MD and Marie Anne Gebara, MD arepaid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.
Beth DiNapoli is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
-
Psychometric Validation of the AASC®: Supporting Early Detection & Improving Caregiver-HCP communication in Agitation Associated With Dementia Due to Alzheimer’s Disease (AAD)
In this webinar, Dr. Carolyn Clevenger will provide both background on AASC® tool development and details on AASC® quantitative validation study design and results.